Upload
others
View
1
Download
0
Embed Size (px)
Citation preview
30-01-2017
1
Observational studies
Jesper Hallas
Professor, MD, DrMedSc
Clinical pharmacology and pharmacy
University of Southern Denmark
Paradigm of epidemiology:
Example : does omeprazole cause femoral neck fractures?
Paradigm 1. Basic eksperiment
Measuring cyclic ATPase activity in murine osteoclast cultures in medium with or without omeprazole.
Paradigm 2. Clinical eksperiment
Double blind, randomised trial where a large group of elderly women are allocated to omeprazole or placebo and are followed up with respect to the occurrence of femoral neck fractures..
Paradigm 3. Clinical observational
A large group of elderly women are contacted and asked about their use of omeprazole. The incidence rate of femoral neck fractures in the follow-up period is compared between users and non-users of omeprazole.
30-01-2017
2
Observational research
� When the investigator does not interfere with study subjects’ exposure (drug use).
� Opposite of experimental / interventional
� Synonyms
� Non-interventional study
� Non-interventional trial
3
Definitions of a ”non-interventional trial” (Clinical Trial Directive 2001/20/EC):
� …a study where the medicinal product(s) is(are) prescribed in the usual manner in accordance with the terms of the marketing authorisation. The assignment of the patient to a particular therapeutic strategy is not decided in advance by a trial protocol but falls within current practise and the prescription of the medicine is clearly separated from the decision to include the patient in the study. No additional diagnostic or monitoring procedures shall be applied to the patients and epidemiological methods shall be used for the analysis of the collected data”
4
30-01-2017
3
Other terms
� Registry studies
� Always observational
� Uses registries as data source
5
Aspects of observational approach
� Scientific
� Ethical
� Regulatory
� Validity
6
30-01-2017
4
Confounding, definition
Bias generated by the lack of comparability between exposed and non-exposed (drug users and non-users).
Confounder: the factor by which they differ
7
Exercise; which confounder explains:
•Users of diet products have fewer femoral neck fractures
than others.
•Persons using a bra have breast cancer more frequently
than others
•Users of low-dose ASA have heart attack more frequently
than others.
30-01-2017
5
Comparability, large randomized clinical trial
LIPID trial, NEJM
1999
Confounder Control
� IN DESIGN
� Randomisation
� Cross-over
� Restriction
� Matching in cohorte studies
� Matching in case-control studies
� IN ANALYSIS
� Standardisation
� Stratification
� Multivariate modelling
� Propensity scores
� Instrumental variables
� Cross-over
� Symmetry analysis
30-01-2017
6
Example, PS matching in observational study
11
Charlot 2010
Other scientific aspects
� Very large n, narrow confidence intervals
� Possibility of long follow-up
� High-quality retrospective studies in registries
� Exploratory analyses
� Not well suited for study of intended effects
� Well suited for adverse effects
12
30-01-2017
7
Ethical
� Risk of harming patient
� Intrusion
� Data confidentiality
13
Harm
14
30-01-2017
8
Intrusion
� Disturbing privacy
� Affecting natural course
� Dealing with impending risk
� Invasive collection of observations
15
Primary vs secondary data
Primary
� Data collected ad hoc
� Nearly always prospective
Secondary
� Data from administrative sources
� Nearly always retrospective
16
30-01-2017
9
Data confidentiality
� Data security at ”Forskermaskine”, Statistics Denmark
� Data are pseudomized, .i.e. CPR is replaced
� Log-on for individual researcher
� Secure connection
� Real-time token
� Security checks
� No output allowed with n<5
� Extensive set of rules in ”Datatilsynet”
� Data are there, anyway
17
Ethical cost of not conducting observational research
18
30-01-2017
10
Legal and regulatory aspects
� In general, observational studies are exempt from GCP
� Exempt from mandatory study registration
� No informed consent
� Pure registry studies are exempt from ethics review in DK
19
ENCEPP
� European Network of Centres for Pharmacoepidemiology and Pharmacovigilanc
� EMA based
� Checklists for research standards
� ENCEPP seal
20
30-01-2017
11
Hybrid studies
� Streamlined trial, pragmatic trials
� Uses randomisation
� Follow-up in registries
� Analysed like epidemiological studies
21
Conditions for performing observationaldrug research in Denmark
22
30-01-2017
12
Danish Medicines AgencyPrescription register
� Established by law 1993
� Operational from 1994
� Covers all 288 Danish retail pharmacies and all hospital pharmacies, alltogether 5,7 mio persons
� Individual-level data, using a one-one encryption of CPR-numbers.
� Covers reimbursed and non-reimbursed prescription drugs
� Established for administrative purposes, not research (!!)
� Provide a detailed individual-level drug utilization statistic
Danish Medicines Agency, output
30-01-2017
13
Danish Medicines Agencyand Danmarks Statistik/Seruminstituttet
� A complete copy of the DKMA prescription register since 1995!
� A complete copy of the Danish Patient Registry since 1977
� Linkage enabled by mutual encrypted CPR-number
� Access through secure connection
� Individual-level data are not given to researchers
� Tables and analyses are transferred by e-mail to the researchers
� ”Forskerserviceenhed”
� Contact: www.dst.dk/forskning
26
30-01-2017
14
DST or SSI?
DST pro
� SES data
� Experience
SSI pro
� No backlog of Rx and Dxdata
� Health data
� Different levels of subscriptions
June 200927
June 200928
30-01-2017
15
Some limitations
� Delay in transfer of data
� Indication in free text
� Dose instruction in free text
� Incomplete capture of magistral preparations
� No capture of hospital dispensed medication
� No capture of over-the-counter dispensings
29
Some strengths
� World’s oldest national individual level prescription database
� Covers nursing homes
30
30-01-2017
16
Important recent development in DK
� Danish register of reimbursed medication
� Hosted by Clinical Epidemiology Unit at ÅU
� Data can be transferred to researchers with CPR-number
� Only covers reimbursed medication
� From 2004 onwards
31
Pharmacoepidemiologic databasesworldwide
Database Population,
million
From
Saskatchewan (Ca) 1 1976
COMPASS (USA) 10 1980
Kaiser Permamente (USA) 2-6 1969
Puget Sound (USA) 0.3 1972
Jämtland, Tierp (S) 0.04 1972
GPRD (UK) 3-4 1987
MEMO (Scotl) 0.4 1989
Odense 1.2 1990
Northern Jutland 1.7 1989
Denmark 5,4 1994
Norway 4,6 2004
Sweden 9 2005
Iceland 0.34 2006
Finland 5 1994
Pharmo, NL 2 1985
30-01-2017
17
Validity
June 200933
30-01-2017
18
Describing the process from prescribing to ingestion
Event
30-01-2017
19
Data on drug exposure
Physician
administrative system,
e.g. GPRD in UK
Pharmacy-based prescription
database, e.g. MEDICAID,
MEMO, OPED
Interview
Event Proxy
Data on drug exposureWhich is best?
Physician administrative
system, e.g. GPRD
Pharmacy-based
prescription database
Interview
Area of major
uncertainty
30-01-2017
20
Studies of data data validity, findings
� Technical data errors are rarely reported
� Non-compliance is substantial and is difficult to ascertain
� Failure to redeem prescriptions is a minor problem for most drug classes
� Databases may have important limitations, e.g. absence of non-subsidized prescription medication
� Recall errors of omission are much more common than errors of commission.
� Recall is dependent on chronicity
Some measures to ensure technical validity
� Bar code technique
� Modulus 11 check, CTR
� Use of Nordic article number
40
30-01-2017
21
Data on drug exposure An example; antibiotics and myocardial infarction
Background: atherosclerosis has been linked to Chlamydia Pneumonia. Antibiotics with effect against CP might protect against AMI
Exposure: any antiobiotic 3 years before the index date.
Cases were 3315 persons with first-time AMI, 13,139 control without AMI. Identified in the GPRD
Meier CR et al. JAMA 1999; 281: 427-31.
Take home messages
� Observational studies do not interfere with subjects’ exposure (drug use)
� Registry studies are observational studies that use registries as data sources
� Main implication
� Scientific: susceptible to confounding (lack of comparability). Possibility of studying rare effects, long-term effects, harms etc.
� Ethical: low risk of harm, confidentiality issue
� Regulatory: important exemptions
� Exceptionally good conditions for conducting observational research in DK
� Validity generally high
42
30-01-2017
22
Backup
43
Regional vs National prescription databases in Denmark
Regional� Only subsidised drugs
� Covers:
� RSD+RS (OPED)
� RN + RM (PDNJ)
� DK (DRSM)
� 1989(90) onwards
� Data can be transferred to other researchers
National� All prescription drugs
� National coverage
� 1995(4) onwards
� Closed circuit in DST or SSI
44
30-01-2017
23
”Study" of anticoagulant effect
Use of oral anticoagulants
and risk of deep-vein thrombosis (DVT)
True risk ratio: <1 (perhaps 0.1?)
Adjusted for age and sex: RR = 27
+ other risk factors for DVT: RR = 4
Miettinen’s conclusions
Confounding by indication can be very strong
It cannot be adjusted completely in a non-
randomised design.
Miettinen OS. The need for randomization in the
study of intended effects. Stat Med 1983; 2: 267-71.